MYCODART
MycoDART Inc., is the developer of molecular diagnostic tests for the rapid detection of deadly infections in very vulnerable patients such as transplant, cancer, and AIDS. Their team has dozens of years experience in business management, laboratory operations, and molecular diagnostics development. They are in the pre-launch stage for MycoDART-PCR Candida Panel. This test will identify Invasive Candidiasis infections earlier and with higher reliability than the current standard of care. As such, it will reduce mortality and cost of treatment for thousands of patients. A panel for Invasive Aspergillosis will follow.
MYCODART
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2018-01-01
Address:
Carrollton, Texas, United States
Country:
United States
Website Url:
http://www.mycodart.com
Status:
Active
Contact:
(972) 947-9779
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag JsDelivr
Similar Organizations
Orphion Therapeutics
Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders.
S1 Biopharma
S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men.
Official Site Inspections
http://www.mycodart.com
- Host name: 104.21.91.218
- IP address: 104.21.91.218
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
